Mochi Health vs Strut Health
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Mochi Health
Best for budget-conscious shoppersStarting at $138/mo
Strut Health
Best for oral-lozenge compounded GLP-1 accessStarting at $99/mo
Side-by-Side Comparison
| Feature | Mochi Health | Strut Health |
|---|---|---|
| Overall Score | 7.7/10 | ✓8.1/10 |
| Starting Price | $138/mo | ✓$99/mo |
| Editorial Rating | 3.9 ★ /5 | ✓4.1 ★ /5 |
| Features | 3 features | ✓6 features |
| States Available | 15 | ✓49 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Mochi Health
Pros
- ✓Aggressively low monthly pricing
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
Cons
- ✗Limited public information on program details
Strut Health
Pros
- ✓Both LegitScript and ACHC accreditation — pharmacy oversight standard most compounded GLP-1 providers don't advertise
- ✓Oral lozenge formulation available for semaglutide ($99/mo) and tirzepatide ($199/mo) — injection-free alternative
- ✓Transparent auto-refill pricing with 13–21% savings vs. one-off orders
- ✓Free unlimited follow-up messaging with board-certified US physicians
- ✓49 states covered (only Arkansas excluded as of September 2024)
Cons
- ✗'Medical necessity' eligibility gate — Strut's prescribers evaluate whether treatment is medically appropriate but the criteria are not publicly defined, so users can't self-screen before paying for a consultation
- ✗Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro option
- ✗Pharmacy partners not publicly named — users can't independently verify 503A/503B compounding source
- ✗No insurance accepted — cash pay only
- ✗Phone consultation requirement varies by state (not every state mandates a synchronous visit)
Our Verdict
Strut Health edges out Mochi Health with a higher overall score of 8.1/10 and is particularly strong for oral-lozenge compounded GLP-1 access. Mochi Health remains a solid alternative, especially if you're looking for budget-conscious shoppers.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.